IP Library Granted Patent US 8,870,763
Granted Patent B2
US 8,870,763 · App. 13/365,406 · Granted Oct 28, 2014

Method and/or system for multicompartment analyte monitoring

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,870,763
App. No.
13/365,406
Granted
Oct 28, 2014
Kind
B2
Abstract

Subject matter disclosed herein relates to monitoring and/or controlling levels of an analyte in bodily fluid. In particular, estimation of a concentration of the analyte in a first physiological compartment based upon observations of a concentration of the analyte in a second physiological compartment may account for a latency in transporting the analyte between the first and second physiological compartments.

Claims (38)

1. A method at least partially executed by a computing apparatus comprising:

modeling a latency in transportation of an analyte between first and second physiological compartments; and

compensating for the latency in estimating a concentration of the analyte in the first physiological compartment based, at least in part, on one or more measurements of a concentration of the analyte in the second physiological compartment by:

combining over time a difference between a sensor signal value and an offset value to provide an integration result;

combining said integration result with a term based, at least in part, on said modeled latency to provide a combined expression; and

determining said estimated concentration based, at least in part, on a computed rate of change in said combined expression.

2. The method of claim 1 , wherein the analyte comprises glucose, the first physiological compartment comprises blood plasma, and the second physiological compartment comprises interstitial fluid.

3. The method of claim 1 , wherein said sensor signal value comprises a measured current responsive to the concentration of said analyte in said second physiological compartment.

4. The method of claim 1 , wherein the latency is based, at least in part, on a latency of a presence of glucose in a patient's interstitial fluid to affect a blood glucose concentration in said patient.

5. The method of claim 4 , wherein the latency is defined based, at least in part, on a time for 63% of glucose in said interstitial fluid to be absorbed by the patient's blood.

6. An apparatus comprising:

a sensor to generate a signal responsive to a concentration of an analyte in a second physiological compartment; and

a processor configured to:

model a latency in transportation of the analyte between the second physiological compartment and a first physiological compartment; and

compensate for the latency in estimating a concentration of the analyte in the first physiological compartment based, at least in part, on the signal responsive to the concentration of the analyte in the second physiological compartment by:

combining over time a difference between a sensor signal value and an offset value to provide an integration result;

combining said integration result with a term based, at least in part, on said modeled latency to provide a combined expression; and

determining said estimated concentration based, at least in part, on a computed rate of change in said combined expression.

7. The apparatus of claim 6 , wherein said sensor signal value comprises a measured current responsive to the concentration of said analyte in said second physiological compartment.

8. The apparatus of claim 6 , wherein the analyte comprises glucose, the first physiological compartment comprises blood plasma, and the second physiological compartment comprises interstitial fluid.

9. The apparatus of claim 6 , wherein the latency is based, at least in part, on a latency of a presence of glucose in a patient's interstitial fluid to affect a blood glucose concentration in said patient.

10. The apparatus of claim 9 , wherein the latency is defined based, at least in part, on a time for 63% of glucose in said interstitial fluid to be absorbed by the patient's blood.

11. The apparatus of claim 6 , the processor configured further to generate a command to one or more infusion pumps computed based, at least in part, on said estimated concentration.

12. An article comprising:

a non-transitory storage medium having machine-readable instructions stored thereon which are executable by a special purpose computing apparatus to:

model a latency in transportation of an analyte between first and second physiological compartments; and

compensate for the latency in estimating a concentration of the analyte in the first physiological compartment based, at least in part, on one or more measurements of a concentration of the analyte in the second physiological compartment by:

combining over time a difference between a sensor signal value and an offset value to provide an integration result;

combining said integration result with a term based, at least in part, on said modeled latency to provide a combined expression; and

determining said estimated concentration based, at least in part, on a computed rate of change in said combined expression.

13. The article of claim 12 , wherein the analyte comprises glucose, the first physiological compartment comprises blood plasma, and the second physiological compartment comprises interstitial fluid.

14. The article of claim 12 , wherein said sensor signal value comprises a measured current responsive to the concentration of said analyte in said second physiological compartment.

15. An apparatus comprising:

means for modeling a latency in transportation of an analyte between first and second physiological compartments; and

means for compensating for the latency in estimating a concentration of the analyte in the first physiological compartment based, at least in part, on one or more measurements of a concentration of the analyte in the second physiological compartment by:

combining over time a difference between a sensor signal value and an offset value to provide an integration result;

combining said integration result with a term based, at least in part, on said modeled latency to provide a combined expression; and

determining said estimated concentration based, at least in part, on a computed rate of change in said combined expression.

Assignments (2)
SECURITY INTEREST Recorded Jan 16, 2026
From: MEDTRONIC MINIMED, INC.; COMPANION MEDICAL, INC.
To: CITIBANK, N.A.
Reel/Frame 074394/0237 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 7, 2012
From: YANG, NING; GOTTLIEB, REBECCA K.; NOGUEIRA, KEITH; LI, XIAOLONG; LIANG, BRADLEY; KANNARD, BRIAN T.
To: MEDTRONIC MINIMED, INC.
Reel/Frame 027821/0418 →